Apple Watch Series 9 & Ultra 2 dodge import ban amid ongoing patent dispute with Masimo. Blood oxygen feature now processes data via paired iPhone. #AppleWatch #Masimo #PatentDispute #TechNews Link: thedailytechfeed.com/apple-watch-...

Apple Watch dodges import ban amid ongoing patent battle with Masimo. Redesigned models shift blood-oxygen processing to iPhone, allowing continued U.S. sales. #AppleWatch #Masimo #PatentDispute Link: thedailytechfeed.com/apple-watch-...

Masimo secures legal win over Apple's Watch blood oxygen sensor, but no ban imposed. A symbolic victory in the ongoing tech patent wars. #Masimo #AppleWatch #PatentDispute #HealthTech Link: thedailytechfeed.com/masimo-wins-...

Zydus follows Lupin with Myrbetriq settlement deal Zydus has joined Lupin in agreeing to settle patent litigation with Astellas on its generic of big-selling overactive bladder drug Myrbetriq.

#ZydusLifesciences has reached a #settlement agreement with #Astellas in a #patentdispute involving #overactivebladder therapy Myrbetriq, which will allow its #generic to remain on sale in the US.

ITC investigates Apple Watch and other smartwatches over alleged fall detection patent infringements by UnaliWear. Potential import bans loom. #AppleWatch #PatentDispute #FallDetection Link: thedailytechfeed.com/apple-watch-...

Apple faces legal action over its Watch's fall detection feature. UnaliWear alleges patent infringement, targeting major tech firms. #AppleWatch #FallDetection #PatentDispute #TechNews Link: thedailytechfeed.com/apple-faces-...

'Skinny' generic Vascepa label case reaches US Supreme Court SCOTUS has agreed to hear a patent dispute between Amarin and Hikma that could have implications for 'skinny labels' used by generic manufacturers.

The Supreme Court of the US (#SCOTUS) has agreed to hear a #patentdispute between #Amarin and #Hikma that could have implications for the legality of '#skinnylabels,' which can help #generic drugmakers bypass #intellectualproperty protections.

pharmaphorum.com/news/skinny-...

Adeia sues AMD — claiming its 3D stacking tech used in Ryzen X3D CPUs infringes patented designs.
Years of talks failed, now it’s in court.
#AMD #Adeia #Semiconductors #TechNews #Ryzen #PatentDispute

You can still buy RingConn smart rings in the US - even after its patent dispute with Oura Ultrahuman, the other smart ring brand included in Oura's patent dispute, has yet to make a similar move.

You can still buy RingConn smart rings in the US - even after its patent dispute with Oura #Technology #ConsumerTechnology #Wearables #SmartRings #WearableTech #PatentDispute

Masimo challenges CBP's reversal allowing Apple to restore blood-oxygen monitoring on Apple Watch, citing patent infringement. Legal battle intensifies. #Masimo #AppleWatch #PatentDispute #HealthTech Link: thedailytechfeed.com/masimo-seeks...

Masimo sues US Customs over approval of Apple Watch imports WASHINGTON (Reuters) -Medical monitoring technology company Masimo (NASDAQ:MASI) sued U.S. Customs and Border Protection on Wednesday over a decision by the agency that allowed Apple (NASDAQ:AAPL) to import Apple Watches with blood-oxygen reading technology during a patent dispute between the companies. Masimo said in the lawsuit in Washington, D.C., federal court that Customs improperly determined that Apple can import watches with pulse oximetry technology, reversing its own decision from last year without notifying Masimo. Masimo told the court that it learned of the agency’s August 1 decision only after Apple announced it would reintroduce blood-oxygen reading to its watches last week. Spokespeople for Apple and Customs did not immediately respond to requests for comment. A Masimo spokesperson declined to comment. Irvine, California-based Masimo has accused Apple of hiring away its employees and stealing its pulse oximetry technology to use in its Apple Watches. Masimo has separately sued Apple for patent infringement and trade secret theft in ongoing federal court cases. Masimo convinced the U.S. International Trade Commission to block imports of Apple’s Series 9 and Ultra 2 smartwatches in 2023 based on a determination that Apple’s technology for reading blood oxygen levels infringed Masimo’s patents. Apple has continued to sell Customs-approved redesigned watches without pulse oximetry since the ITC (NSE:ITC)’s decision. Apple said on Aug. 14 that it would reintroduce its smartwatches’ blood-oxygen reading capabilities with approval from Customs. Masimo said the agency’s decision to approve the watches without input from Masimo or any "meaningful justification" deprived the company of its rights. Masimo asked the Washington court to halt the agency’s ruling and continue to block Apple from selling watches with the blood-oxygen feature. With valuations skyrocketing in 2024, many investors are uneasy putting more money into stocks. Sure, there are always opportunities in the stock market – but finding them feels more difficult now than a year ago. Unsure where to invest next? One of the best ways to discover new high-potential opportunities is to look at the top performing portfolios this year. ProPicks AI offers 6 model portfolios from Investing.com which identify the best stocks for investors to buy right now. For example, ProPicks AI found 9 overlooked stocks that jumped over 25% this year alone. The new stocks that made the monthly cut could yield enormous returns in the coming years. Is AAPL one of them?

Click Subscribe #Masimo #AppleWatch #CustomsLawsuit #PatentDispute #MedicalTechnology

Apple appeals U.S. ban on blood-oxygen feature in Apple Watches, challenging ITC's ruling favoring Masimo. #Apple #Masimo #AppleWatch #PatentDispute #HealthTech Link: thedailytechfeed.com/apple-challe...

Google's Pixel 7 series faces a sales ban in Japan due to patent infringement. Potential extensions to newer models could impact Google's market growth. #GooglePixel #PatentDispute #JapanTechNews Link: thedailytechfeed.com/google-pixel...

Apple must pay Optis $502 million lump sum in UK patent dispute, court rules LONDON (Reuters) -Apple must pay a U.S. patent holder $502 million for the use of 4G patents in devices including iPhones and iPads, London’s Court of Appeal ruled on Thursday, in the latest stage of a long-running legal battle. Texas-based Optis Cellular Technology LLC sued Apple (NASDAQ:AAPL) in London in 2019 over its use of patents which Optis says are essential to certain technological standards, such as 4G. London’s High Court ruled in 2023 that Apple should pay Optis a total of $56.43 million plus interest to cover past and future sales over a set period. But Optis argued that was far too low and challenged the decision at an appeal heard in February and March. The Court of Appeal said in a partially-redacted written ruling that Apple should pay a lump sum of $502 million, not including interest, for the period from 2013 to 2027. The lump sum relates to a global licence to use Optis’ patents. An Apple spokesperson said they were "disappointed by this decision and plan to appeal". "Optis makes no products and their sole business is to sue companies using patents they buy," the spokesperson added. "We will continue to defend against their attempts to extract unreasonable payments." Thursday’s ruling is the latest decision in the legal battle between Apple and Optis over the FRAND (fair, reasonable and non-discriminatory) terms to use Optis’ patents.

Click Subscribe #Apple #Optis #PatentDispute #CourtRuling #4G

Apple Watch Import Ban Lifted as Court Rules in Apple’s Favor The potential Apple Watch import ban has been lifted as a U.S. court rules in Apple's favor against AliveCor in a patent dispute over ECG technology.

Breaking: Major legal victory for Apple 🏛️ PTAB rules against AliveCor in ECG patent dispute, ending potential Apple Watch import ban. What does this mean for wearable tech innovation? Read more.

#AppleWatch #AliveCor #PatentDispute #TechLaw

true-tech.net/apple-watch-...

Lenovo, Ericsson settle international patent dispute LONDON (Reuters) -Lenovo said on Thursday it and Ericsson (BS:ERICAs) had reached an agreement on a global patent cross-licence and to settle all pending litigation, ending a worldwide legal battle. Lenovo sued Ericsson in London in 2023, one of a number of cases brought by one or other of the two companies around the world over 4G and 5G wireless technology. The pair had also sued one another in Brazil, Colombia and the United States, both in North Carolina and at the U.S. International Trade Commission. Their dispute centred on the fair, reasonable, and non-discriminatory (FRAND) terms for a licence to use Lenovo and Ericsson’s patents. Lenovo said on Thursday that it had reached an agreement with Ericsson, with the parties entering into binding arbitration to determine the final terms. Thursday’s announcement comes in the same week that Amazon (NASDAQ:AMZN) and Nokia (HE:NOKIA) said they had settled their global patent dispute.

Click Subscribe #Lenovo #Ericsson #PatentDispute #TechNews #LegalSettlement

Lenovo Wins UK Appeal in High-Stakes 5G Patent Dispute with Ericsson - WIOBS Lenovo secures a legal victory in the UK over Ericsson in their ongoing 5G patent dispute, setting a precedent for FRAND licensing...

Lenovo Wins UK Appeal in High-Stakes 5G Patent Dispute with Ericsson
wiobs.com/lenovo-wins-...
#Lenovo #Ericsson #5G #PatentDispute #FRAND #Telecom #UKCourt #TechLaw #IntellectualProperty

🍏 Apple's dispute with Omni Bridgeway sheds light on the clash between tech giants and small patent holders. Will litigation funders be able to shield their communications? #Apple #LitigationFunding #PatentDispute #OmniBridgeway

https://buff.ly/4cP1ohF

"Infineon's gallium nitride patent complaint faces hurdles in California court, but the real showdown lies ahead on induced infringement. Read more on the latest developments. #Infineon #Innoscience #PatentDispute #GalliumNitride #LegalNews"

https://buff.ly/3W8z04V

"Abbott seeks to invalidate Dexcom's glucose monitor patent in Europe, intensifying rivalry. Stay ahead of legal developments with Law360's expert analysis and real-time alerts. Subscribe for a free 7-day trial now! #LegalNews #PatentDispute #Law360" http://dlvr.it/T7wycy

Apple fights back: Urges US appeals court to overturn US ITC's ban on certain Apple Watch imports amidst patent dispute with Masimo. Legal showdown intensifies. #Apple #ITC #PatentDispute